D Proud

Author PubWeight™ 133.12‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Infection of a human respiratory epithelial cell line with rhinovirus. Induction of cytokine release and modulation of susceptibility to infection by cytokine exposure. J Clin Invest 1995 2.05
2 Kinins are generated in vivo following nasal airway challenge of allergic individuals with allergen. J Clin Invest 1983 2.05
3 Inflammatory mediators in late antigen-induced rhinitis. N Engl J Med 1985 1.84
4 Detection of tissue kallikrein in the bronchoalveolar lavage fluid of asthmatic subjects. J Clin Invest 1987 1.80
5 Mutation in the gene responsible for cystic fibrosis and predisposition to chronic rhinosinusitis in the general population. JAMA 2000 1.62
6 Antigen-specific IgE and IgA antibodies in bronchoalveolar lavage fluid are associated with stronger antigen-induced late phase reactions. Clin Exp Allergy 2001 1.46
7 Nasal challenge with cold, dry air results in release of inflammatory mediators. Possible mast cell involvement. J Clin Invest 1985 1.45
8 Kinins are generated during experimental rhinovirus colds. J Infect Dis 1988 1.44
9 Cyclooxygenase metabolism of endogenous arachidonic acid by cultured human tracheal epithelial cells. Am Rev Respir Dis 1989 1.41
10 Evidence for elevated levels of histamine, prostaglandin D2, and other bronchoconstricting prostaglandins in the airways of subjects with mild asthma. Am Rev Respir Dis 1990 1.40
11 Immediate and late inflammatory responses to ragweed antigen challenge of the peripheral airways in allergic asthmatics. Cellular, mediator, and permeability changes. Am Rev Respir Dis 1991 1.38
12 Immunotherapy decreases antigen-induced eosinophil cell migration into the nasal cavity. J Allergy Clin Immunol 1991 1.37
13 Expression of the chemokine RANTES by a human bronchial epithelial cell line. Modulation by cytokines and glucocorticoids. J Immunol 1995 1.33
14 Studies of IgE-dependent histamine releasing factors: heterogeneity of IgE. J Immunol 1987 1.32
15 Identification of a chymotrypsin-like proteinase in human mast cells. J Immunol 1986 1.29
16 Upper respiratory tract environmental tobacco smoke sensitivity. Am Rev Respir Dis 1991 1.27
17 Nitric oxide inhibits rhinovirus-induced cytokine production and viral replication in a human respiratory epithelial cell line. J Virol 1998 1.26
18 Elevation of tissue kallikrein and kinin in the airways of asthmatic subjects after endobronchial allergen challenge. Am Rev Respir Dis 1992 1.21
19 Characterization of vagal afferent subtypes stimulated by bradykinin in guinea pig trachea. J Pharmacol Exp Ther 1999 1.20
20 Bradykinin antagonists. Annu Rev Pharmacol Toxicol 1991 1.19
21 Production of granulocyte-macrophage colony-stimulating factor by cultured human tracheal epithelial cells. Immunology 1992 1.14
22 Differential regulation of epithelial-derived C-C chemokine expression by IL-4 and the glucocorticoid budesonide. J Immunol 1999 1.14
23 Epithelia cells as regulators of airway inflammation. J Allergy Clin Immunol 1998 1.12
24 Nasal challenge with ragweed pollen in hay fever patients. Effect of immunotherapy. J Clin Invest 1985 1.11
25 In vivo release of inflammatory mediators by hyperosmolar solutions. Am Rev Respir Dis 1988 1.08
26 Human lung macrophage-derived histamine-releasing activity is due to IgE-dependent factors. J Immunol 1986 1.05
27 Human eosinophil-granule major basic protein and synthetic polycations induce airway hyperresponsiveness in vivo dependent on bradykinin generation. J Clin Invest 1995 1.04
28 Cigarette smoke modulates rhinovirus-induced airway epithelial cell chemokine production. Eur Respir J 2009 1.02
29 Effects of prednisone on the cellular responses and release of cytokines and mediators after segmental allergen challenge of asthmatic subjects. J Allergy Clin Immunol 2001 1.00
30 Human lung macrophages induce histamine release from basophils and mast cells. Am Rev Respir Dis 1985 1.00
31 Characterization and localization of human renal kininogen. J Biol Chem 1981 1.00
32 Influx of kininogens into nasal secretions after antigen challenge of allergic individuals. J Clin Invest 1985 0.99
33 Detection and partial characterization of a human mast cell carboxypeptidase. J Immunol 1987 0.99
34 Effect of intranasal capsaicin on symptoms and mediator release. J Pharmacol Exp Ther 1991 0.98
35 Inhibition of mediator release in allergic rhinitis by pretreatment with topical glucocorticosteroids. N Engl J Med 1987 0.98
36 Human lung macrophages enhance and inhibit lymphocyte proliferation. J Immunol 1984 0.98
37 Stable expression of the human kinin B1 receptor in Chinese hamster ovary cells. Characterization of ligand binding and effector pathways. J Biol Chem 1997 0.97
38 A randomized controlled trial of glucocorticoid prophylaxis against experimental rhinovirus infection. J Infect Dis 1990 0.97
39 Basophil histamine release induced by a substance from stimulated human platelets. J Immunol 1986 0.97
40 Terfenadine, an H1 antihistamine, inhibits histamine release in vivo in the human. Am Rev Respir Dis 1990 0.96
41 Role of NF-kappa B in cytokine production induced from human airway epithelial cells by rhinovirus infection. J Immunol 2000 0.96
42 Studies on the allergic and nonallergic nasal inflammation. J Allergy Clin Immunol 1988 0.95
43 Effect of short-term systemic glucocorticoid treatment on human nasal mediator release after antigen challenge. J Clin Invest 1987 0.95
44 Effects of tumor necrosis factor-alpha, epidermal growth factor and transforming growth factor-alpha on interleukin-8 production by, and human rhinovirus replication in, bronchial epithelial cells. Int Immunopharmacol 2001 0.95
45 Oral prednisone therapy in experimental rhinovirus infections. J Allergy Clin Immunol 1996 0.95
46 A human lung mast cell chymotrypsin-like enzyme. Identification and partial characterization. J Clin Invest 1986 0.94
47 Characterization of kinin receptors on human synovial cells and upregulation of receptor number by interleukin-1. J Pharmacol Exp Ther 1992 0.94
48 Activation of antiviral protein kinase leads to immunoglobulin E class switching in human B cells. J Virol 1998 0.94
49 Dose-dependent effects of capsaicin nasal challenge: in vivo evidence of human airway neurogenic inflammation. J Allergy Clin Immunol 1997 0.94
50 Immunoglobulin E-mediated release of a kininogenase from purified human lung mast cells. Am Rev Respir Dis 1985 0.93
51 Nerve growth factor expression and release in allergic inflammatory disease of the upper airways. Am J Respir Crit Care Med 2000 0.93
52 The immunological similarity of rat glandular kallikreins. Biochem J 1977 0.93
53 Local generation of sulfidopeptide leukotrienes upon nasal provocation with cold, dry air. Am Rev Respir Dis 1986 0.92
54 Kinin metabolism in human nasal secretions during experimentally induced allergic rhinitis. J Immunol 1987 0.92
55 Sinus mucosal IL-8 gene expression in chronic rhinosinusitis. J Allergy Clin Immunol 1999 0.92
56 Kallikrein-kinin and renin-angiotensin systems in rat renal lymph. Kidney Int 1984 0.92
57 Concentrations of glandular kallikrein in human nasal secretions increase during experimentally induced allergic rhinitis. J Immunol 1986 0.91
58 Rhinovirus infection induces expression of type 2 nitric oxide synthase in human respiratory epithelial cells in vitro and in vivo. J Allergy Clin Immunol 2001 0.90
59 Radioimmunoassay of human high molecular weight kininogen in normal and deficient plasmas. J Lab Clin Med 1980 0.90
60 Influence of the cytosolic carboxyl termini of human B1 and B2 kinin receptors on receptor sequestration, ligand internalization, and signal transduction. J Biol Chem 1998 0.89
61 Effect of ozone inhalation on the response to nasal challenge with antigen of allergic subjects. Am Rev Respir Dis 1990 0.89
62 Characterization and origin of immunoreactive glandular kallikrein in rat plasma. Biochem Pharmacol 1981 0.89
63 Acute respiratory response to prolonged, moderate levels of sidestream tobacco smoke. J Toxicol Environ Health A 1998 0.89
64 Nitric oxide inhibits rhinovirus-induced granulocyte macrophage colony-stimulating factor production in bronchial epithelial cells. Am J Respir Cell Mol Biol 2001 0.89
65 Platelet activation in the lung after antigen challenge in a model of allergic asthma. Am Rev Respir Dis 1992 0.88
66 Preincubation of human synovial cells with IL-1 modulates prostaglandin E2 release in response to bradykinin. J Immunol 1989 0.88
67 Plasma kallikrein during experimentally induced allergic rhinitis: role in kinin formation and contribution to TAME-esterase activity in nasal secretions. J Immunol 1986 0.88
68 In vivo and in vitro effects of antihistamines on mast cell mediator release: a potentially important property in the treatment of allergic disease. Ann Allergy 1989 0.87
69 The location of prekallikrein in the rat pancreas [proceedings]. Biochem Soc Trans 1977 0.87
70 Neutrophil transmigration across human airway epithelial monolayers: mechanisms and dependence on electrical resistance. Am J Respir Cell Mol Biol 2000 0.87
71 Distribution of immunoreactive kallikrein along the rat nephron. Am J Physiol 1983 0.87
72 The osmolality of nasal secretions increases when inflammatory mediators are released in response to inhalation of cold, dry air. Am Rev Respir Dis 1988 0.87
73 Observations on the pathogenesis of nasal priming. J Allergy Clin Immunol 1989 0.86
74 Antimicrobial peptides in lung transplant recipients with bronchiolitis obliterans syndrome. Eur Respir J 2008 0.86
75 Nasal provocation with allergen induces a secondary serum IgE antibody response. J Allergy Clin Immunol 1997 0.86
76 Differences between basophils and mast cells: failure to detect Charcot-Leyden crystal protein (lysophospholipase) and eosinophil granule major basic protein in human mast cells. J Immunol 1986 0.85
77 Effects of immunotherapy on the early, late, and rechallenge nasal reaction to provocation with allergen: changes in inflammatory mediators and cells. J Allergy Clin Immunol 1991 0.85
78 Profiling of bisenoic prostaglandins and thromboxane B2 in bronchoalveolar fluid from the lower respiratory tract of human subjects by combined capillary gas chromatography-mass spectrometry. Prostaglandins 1988 0.84
79 Major basic protein and eosinophil-derived neurotoxin concentrations in nasal-lavage fluid after antigen challenge: effect of systemic corticosteroids and relationship to eosinophil influx. J Allergy Clin Immunol 1989 0.84
80 A competitive kinin receptor antagonist, [DArg0, Hyp3, DPhe7]-bradykinin, does not affect the response to nasal provocation with bradykinin. Br J Clin Pharmacol 1991 0.84
81 Evidence that enhanced nasal reactivity to bradykinin in patients with symptomatic allergy is mediated by neural reflexes. J Allergy Clin Immunol 1996 0.84
82 Comparison of nasal mucosal responsiveness to neuronal stimulation in non-allergic and allergic rhinitis: effects of capsaicin nasal challenge. Clin Exp Allergy 1998 0.84
83 Ozone exposure in humans: inflammatory, small and peripheral airway responses. Am J Respir Crit Care Med 1995 0.84
84 Cultured human synovial fibroblasts rapidly metabolize kinins and neuropeptides. J Clin Invest 1992 0.84
85 Effects of intranasal administration of endothelin-1 to allergic and nonallergic individuals. Am J Respir Crit Care Med 1995 0.84
86 Inflammatory mediators and mechanisms of release from purified human basophils and mast cells. J Allergy Clin Immunol 1984 0.83
87 Inflammatory mediators in nasal secretions during induced rhinitis. Clin Allergy 1986 0.83
88 The human nasal response to capsaicin. J Allergy Clin Immunol 1994 0.83
89 Demonstration of inhibition of mediator release from human mast cells by azatadine base. In vivo and in vitro evaluation. JAMA 1986 0.82
90 Dexamethasone inhibits plasminogen activator activity in experimental pemphigus in vivo but does not block acantholysis. J Immunol 1986 0.82
91 Studies on the relationships between sensitivity to cold, dry air, hyperosmolal solutions, and histamine in the adult nose. Am Rev Respir Dis 1990 0.82
92 Mediator release during nasal provocation. A model to investigate the pathophysiology of rhinitis. Am J Med 1985 0.81
93 Measles virus infection synergizes with IL-4 in IgE class switching. J Immunol 1999 0.81
94 Antigen-provoked increase in histamine reactivity. Observations on mechanisms. Am Rev Respir Dis 1991 0.81
95 Responses to ragweed-pollen nasal challenge before and after immunotherapy. J Allergy Clin Immunol 1989 0.81
96 Intranasal beclomethasone inhibits antigen-induced nasal hyperresponsiveness to histamine. J Allergy Clin Immunol 1992 0.81
97 Allergen-induced hyperresponsiveness to bradykinin is more pronounced than that to methacholine. J Appl Physiol (1985) 1995 0.81
98 Arachidonic acid metabolites during nasal challenge. Arch Otolaryngol Head Neck Surg 1987 0.81
99 Ragweed IgE and IgG4 antibody in nasal secretions during immunotherapy. Clin Exp Allergy 1990 0.80
100 A double-blind study of the discontinuation of ragweed immunotherapy. J Allergy Clin Immunol 1997 0.80
101 Relationship between histamine and physiological changes during the early response to nasal antigen provocation. J Appl Physiol (1985) 1999 0.80
102 Interaction of platelet-activating factor with cultured guinea pig tracheal epithelial cells. Biochem J 1991 0.80
103 The effect of a topical tricyclic antihistamine on the response of the nasal mucosa to challenge with cold, dry air and histamine. J Allergy Clin Immunol 1987 0.80
104 Comparison of the responses of B1 and B2 kinin receptors to agonist stimulation. Immunopharmacology 1999 0.80
105 Mechanisms of prostanoid synthesis in human synovial cells: cytokine-peptide synergism. Inflammation 1996 0.80
106 Clinical and immunologic effects of component peptides in Allervax Cat. Int Arch Allergy Immunol 1997 0.80
107 Kinins are generated in nasal secretions during influenza A infections in ferrets. Am Rev Respir Dis 1990 0.80
108 Effect of alterations in extracellular fluid volume on urinary kallikrein in the conscious rat. Hypertension 1982 0.80
109 Effects of loratadine and terfenadine on the induced nasal allergic reaction. Arch Otolaryngol Head Neck Surg 1996 0.80
110 Rapid purification of a prekallikrein from rat pancreas. Anal Biochem 1981 0.80
111 The pathophysiology of human mast cells. In vitro and in vivo function. Am Rev Respir Dis 1987 0.79
112 Theophylline reduces histamine release during pollen-induced rhinitis. J Allergy Clin Immunol 1986 0.79
113 Is histamine responsible for the symptoms of rhinovirus colds? A look at the inflammatory mediators following infection. Pediatr Infect Dis J 1988 0.79
114 A new kinin moiety in human plasma kininogens. Biochem Biophys Res Commun 1988 0.79
115 Modulation of kinin responses in human synovium by interleukin-1. Agents Actions Suppl 1992 0.78
116 Creatine supplementation as an exercise performance enhancer for patients with COPD? An idea to run with. Thorax 2005 0.78
117 Mechanisms of mediator release from human skin mast cells upon stimulation by the bradykinin analog, [DArg0-Hyp3-DPhe7]bradykinin. Biochem Pharmacol 1991 0.78
118 The effect of cetirizine on early allergic response. Laryngoscope 1989 0.78
119 Experimentally induced nasal allergic responses. J Allergy Clin Immunol 1988 0.78
120 Bradykinin is a potent and relatively selective stimulus for cytosolic calcium elevation in human synovial cells. J Immunol 1994 0.78
121 Transient exposure of human bronchial epithelial cells to cytokines leads to persistent increased expression of ICAM-1. Inflammation 2001 0.78
122 Effects of restriction of sodium or administration of fludrocortisone on parotid salivary kallikrein in man. J Lab Clin Med 1982 0.78
123 A sensitive colorimetric assay for the release of tryptase from human lung mast cells in vitro. J Immunol Methods 1993 0.78
124 Theophylline reduces the response to nasal challenge with antigen. Am J Med 1985 0.78
125 Plasma extravasation through neuronal stimulation in human nasal mucosa in the setting of allergic rhinitis. J Appl Physiol (1985) 1998 0.77
126 The role of kinins in human allergic disease. N Engl Reg Allergy Proc 1987 0.77
127 Relationship between the early, late, and rechallenge reaction to nasal challenge with antigen: observations on the role of inflammatory mediators and cells. J Allergy Clin Immunol 1990 0.77
128 Dissociation of bradykinin-induced plasma exudation and reactivity in the peripheral airways. Am J Respir Crit Care Med 1996 0.77
129 Characterization of GTP-binding proteins coupled to inhibition of adenylyl cyclase in guinea pig tracheal epithelial cells. Am J Respir Cell Mol Biol 1994 0.77
130 Pharmacology of nasal provocation with bradykinin: studies of tachyphylaxis, cyclooxygenase inhibition, alpha-adrenergic stimulation, and receptor subtype. Int Arch Allergy Appl Immunol 1991 0.77
131 The effect of azelastine on the early allergic response. Clin Exp Allergy 1992 0.77
132 Local application of atropine attenuates the upper airway reaction to cold, dry air. Am Rev Respir Dis 1992 0.77
133 Induction of histamine release from human skin mast cells by bradykinin analogs. Biochem Pharmacol 1989 0.77
134 Cold dry air-induced rhinitis: effect of inhalation and exhalation through the nose. J Appl Physiol (1985) 1995 0.77
135 Is leukotriene B4 an important mediator in human IgE-mediated allergic reactions? Am Rev Respir Dis 1987 0.76
136 Inhibition of human bronchial kallikrein in asthma. Am Rev Respir Dis 1989 0.76
137 Enhancement of afferent nerve excitability in the airways by allergic inflammation. Pulm Pharmacol 1996 0.76
138 Allergen-induced changes in airway responsiveness are not related to indices of airway edema. J Allergy Clin Immunol 2001 0.76
139 Bradykinin analog induce histamine release from human skin mast cells. Adv Exp Med Biol 1989 0.76
140 Soluble intracellular adhesion molecule 1 in bronchoalveolar lavage fluid of allergic subjects following segmental antigen challenge. Am J Respir Crit Care Med 1994 0.76
141 Disassociation of the release of histamine and arachidonic acid metabolites from osmotically activated basophils and human lung mast cells. Am Rev Respir Dis 1990 0.75
142 Airways hyper-responsiveness to bradykinin and methacholine: effects of inhaled fluticasone. Clin Exp Allergy 2002 0.75
143 The effect of a leukotriene antagonist on the early response to antigen. Otolaryngol Head Neck Surg 1990 0.75
144 Stronger nasal responsiveness to cold air in individuals with rhinitis and asthma, compared with rhinitis alone. Clin Exp Allergy 2006 0.75
145 Human plasma prekallikrein and high molecular weight kininogen decrease during parturition. Thromb Res 1984 0.75
146 Nasal challenge with cold, dry air induces a late-phase reaction. Am Rev Respir Dis 1988 0.75
147 Burning up the disposable income. Health Serv J 1988 0.75
148 Ketotifen reduces sneezing but not histamine release following nasal challenge with antigen. Clin Exp Allergy 1990 0.75
149 Histamine release from human basophils is induced by IgE-dependent factor(s) derived from human lung macrophages and an Fc epsilon receptor-positive human B cell line. Trans Assoc Am Physicians 1985 0.75
150 The effect of a histamine synthesis inhibitor on the immediate nasal allergic reaction. Allergy 1987 0.75
151 Kininogens in nasal secretions after allergen challenge. Adv Exp Med Biol 1986 0.75
152 Cardiac transplantation. Lamp 1989 0.75
153 Pharmacology of upper airways challenge. Int Arch Allergy Appl Immunol 1987 0.75
154 Cardiac transplant. A nursing perspective. Qld Nurse 1985 0.75
155 Observations on nasal late phase reactions. Immunol Invest 1988 0.75
156 Sodium-retaining steroids increase parotid salivary kallikrein. Adv Exp Med Biol 1983 0.75
157 Airway neural responses to kinins: tachyphylaxis and role of receptor subtypes. Am J Respir Crit Care Med 1999 0.75
158 Kinins as mediators of human allergic reactions. Adv Exp Med Biol 1986 0.75
159 The nasal response to histamine challenge: effect of the pollen season and immunotherapy. J Allergy Clin Immunol 1992 0.75
160 Histamine stimulation of the nasal mucosa does not induce prostaglandin or leukotriene generation or induce methacholine hyperresponsiveness. Int Arch Allergy Appl Immunol 1991 0.75
161 The role of inflammatory mediators in allergic rhinitis. Ear Nose Throat J 1986 0.75
162 Origin of late phase histamine release. J Allergy Clin Immunol 1996 0.75
163 Steroid-induced reduction of histamine release does not alter the clinical nasal response to cold, dry air. Am Rev Respir Dis 1991 0.75
164 Attenuation of allergen sensitivity early in the course of ragweed immunotherapy. J Allergy Clin Immunol 1989 0.75
165 Lack of effect of hot, humid air on response to nasal challenge with histamine. Ann Otol Rhinol Laryngol 1996 0.75
166 Immunoreactive kallikrein in rat renal lymph. Adv Exp Med Biol 1983 0.75
167 Evaluation of a bedtime dose of a combination antihistamine/analgesic/decongestant product on antigen challenge the next morning. Laryngoscope 1992 0.75
168 The effects of H1 antihistamines on the early allergic response. Ann Allergy 1989 0.75
169 Daily variations of serum diamine oxidase and the influence of H1 and H2 blockers: a critical approach to routine diamine oxidase assessment. Inflamm Res 1998 0.75
170 Treatment with hot, humid air reduces the nasal response to allergen challenge. J Allergy Clin Immunol 1997 0.75
171 Comparison of the in-vivo and in-vitro response to ragweed immunotherapy in children and adults with ragweed-induced rhinitis. Clin Exp Allergy 1990 0.75
172 Localized antigen challenge of the nasal mucosa. Arch Otolaryngol Head Neck Surg 1990 0.75